以“信立泰药业外方是什么”为关键词的文章

中文：

信立泰药业是一家中外合资企业，其外方是Salubris Biotherapeutics AG，一家瑞士生物技术公司。Salubris Biotherapeutics AG专注于开发和生产创新型生物技术药物，拥有强大的研发实力和丰富的产品线。作为信立泰药业的外方，Salubris Biotherapeutics AG为信立泰药业提供了技术支持和业务合作，共同推动信立泰药业的发展。同时，信立泰药业也积极引进外方的先进技术和管理经验，提升自身的研发和生产能力，加速产品的上市进程。

英文：

Xinli Taidih Pharmaceutical is a Sino-foreign joint venture, with its foreign party being Salubris Biotherapeutics AG, a Swiss biotechnology company. Salubris Biotherapeutics AG focuses on the development and production of innovative biotechnology drugs, with strong R&D capabilities and a rich product pipeline. As the foreign party of Xinli Taidih Pharmaceutical, Salubris Biotherapeutics AG provides technical support and business cooperation to Xinli Taidih Pharmaceutical, jointly promoting the development of the latter. At the same time, Xinli Taidih Pharmaceutical also actively introduces advanced technology and management experience from the foreign party to enhance its R&D and production capabilities, and accelerate the launch process of its products.